Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation.

Abnormalities of fatty acid metabolism are recognized to play a significant role in human disease, but the mechanisms remain poorly understood. Long-chain acyl-CoA dehydrogenase (LCAD) catalyzes the initial step in mitochondrial fatty acid oxidation (FAO). We produced a mouse model of LCAD deficiency with severely impaired FAO. Matings between LCAD +/- mice yielded an abnormally low number of LCAD +/- and -/- offspring, indicating frequent gestational loss. LCAD -/- mice that reached birth appeared normal, but had severely reduced fasting tolerance with hepatic and cardiac lipidosis, hypoglycemia, elevated serum free fatty acids, and nonketotic dicarboxylic aciduria. Approximately 10% of adult LCAD -/- males developed cardiomyopathy, and sudden death was observed in 4 of 75 LCAD -/- mice. These results demonstrate the crucial roles of mitochondrial FAO and LCAD in vivo.

[1]  T. Cowan,et al.  Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. , 1998, The Journal of pediatrics.

[2]  P. Divry,et al.  Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[3]  Y. Dong,et al.  Characterization of human and pig kidney long-chain-acyl-CoA dehydrogenases and their role in beta-oxidation. , 1997, European journal of biochemistry.

[4]  G. Boden.  Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.

[5]  C. Stanley,et al.  Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. , 1996, The American journal of gastroenterology.

[6]  P. Leder,et al.  Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.

[7]  J. Vockley,et al.  Identification of the active site catalytic residue in human isovaleryl-CoA dehydrogenase. , 1995, Biochemistry.

[8]  M. Bennett,et al.  Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile. , 1995, Clinical chemistry.

[9]  T. Aoyama,et al.  Cloning of human very-long-chain acyl-coenzyme A dehydrogenase and molecular characterization of its deficiency in two patients. , 1995, American journal of human genetics.

[10]  P. A. Wood,et al.  RNA expression and chromosomal location of the mouse long-chain acyl-CoA dehydrogenase gene. , 1995, Genomics.

[11]  M G Blitzer,et al.  Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver. , 1994, Human pathology.

[12]  L. Opie,et al.  Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias , 1994, The Lancet.

[13]  T. Hashimoto,et al.  Identification of Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency in Three Patients Previously Diagnosed with Long-Chain Acyl-CoA Dehydrogenase Deficiency , 1993, Pediatric Research.

[14]  C. Vianey‐Saban,et al.  Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts. , 1993, Biochimica et biophysica acta.

[15]  P. A. Wood,et al.  Short-Chain Acyl-Coenzyme A Dehydrogenase Activity, Antigen, and Biosynthesis Are Absent in the BALB/cByJ Mouse , 1992, Pediatric Research.

[16]  T Hashimoto,et al.  Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl-coenzyme A dehydrogenase. , 1992, The Journal of biological chemistry.

[17]  S. Litwin,et al.  Induction of Myocardial Hypertrophy After Coronary Ligation in Rats Decreases Ventricular Dilatation and Improves Systolic Function , 1991 .

[18]  W. T. Cave,et al.  Dietary n‐3 (ω‐3) polyunsaturated fatty acid effects on animal tumorigenesis , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  F. Kummerow.  Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects , 1991 .

[20]  Allan Bradley,et al.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.

[21]  K. Tanaka,et al.  Molecular basis of medium chain acyl-coenzyme A dehydrogenase deficiency. An A to G transition at position 985 that causes a lysine-304 to glutamate substitution in the mature protein is the single prevalent mutation. , 1990, The Journal of clinical investigation.

[22]  D. Millington,et al.  Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue. , 1989, Analytical biochemistry.

[23]  K. Tanaka,et al.  Molecular cloning and nucleotide sequence of complementary DNAs encoding human short chain acyl-coenzyme A dehydrogenase and the study of the molecular basis of human short chain acyl-coenzyme A dehydrogenase deficiency. , 1989, The Journal of clinical investigation.

[24]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[25]  Jack W. Szostak,et al.  The double-strand-break repair model for recombination , 1983, Cell.

[26]  G. Mannaerts,et al.  MITOCHONDRIAL AND PEROXISOMAL β‐OXIDATION OF FATTY ACIDS IN RAT LIVER , 1982 .

[27]  P. A. Wood,et al.  Short-Chain Acyl-Coenzyme A Dehydrogenase Deficiency in Mice , 1989, Pediatric Research.

[28]  D. Nicholls,et al.  Thermogenic mechanisms in brown fat. , 1984, Physiological reviews.